- 公司资讯
- 富途 | 2022年12月08日 20:23一图读懂 | 盯紧华尔街有肉吃？机构齐声认可明年这一方向，并给出选股名单
- finviz | 2022年09月27日 20:00Sevredent Sourcing Solutions and Pacira BioSciences Collaborate to Provide Expanded Access to EXPAREL for Patients Undergoing Oral and Maxillofacial Procedures
- finviz | 2022年09月22日 06:04Pacira (PCRX) Gets Positive CHMP View on Exparel Label Expansion
- finviz | 2022年09月21日 22:08Pacira Touts Positive Data From EXPAREL Study In Toe Correction Surgery
- finviz | 2022年09月21日 20:00Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Sciatic Nerve Block in the Popliteal Fossa for Bunionectomy
- finviz | 2022年09月20日 20:00Pacira Receives Positive CHMP Opinion for EXPAREL
- finviz | 2022年09月13日 20:00Pacira BioSciences Reports Preliminary Net Product Sales of $59.1 Million for August 2022
- finviz | 2022年09月08日 22:42Pacira (PCRX) Up on Data From Exparel Label Expansion Study
- finviz | 2022年09月07日 23:07Pacira Posts Topline Data From Knee Surgery Study With Its Flagship Pain Management Drug
- finviz | 2022年09月07日 19:00Pacira BioSciences Announces Positive Topline Data from Phase 3 Study of EXPAREL as a Single-dose Femoral Nerve Block in the Adductor Canal for Total Knee Arthroplasty
- finviz | 2022年09月02日 23:31Why Is Pacira (PCRX) Down 9.2% Since Last Earnings Report?
- finviz | 2022年08月10日 20:00Pacira BioSciences Reports Preliminary Net Product Sales of $50.2 Million for July 2022
- finviz | 2022年08月09日 19:30NFL Alumni Association and Pacira BioSciences Team Up to Educate Athletes and Communities About Non-Opioid Options to Manage Pain
- finviz | 2022年08月03日 21:15Pacira (PCRX) Misses Q2 Earnings and Revenue Estimates
- finviz | 2022年08月03日 20:00Pacira BioSciences Reports Second Quarter 2022 Financial Results
- finviz | 2022年08月02日 20:00Pacira BioSciences to Participate in Fireside Chat at the 2022 Wedbush PacGrow Healthcare Virtual Conference
首页
上页
下页